Pontifax, a venture capital firm founded in 2004, manages $350M+ to fund transformative life sciences technologies.
Location
Herzliya, Tel Aviv District, IL
Founded
2004
Pontifax is a healthcare-focused venture capital firm managing over $350 million. They invest in transformative life sciences technologies across all development stages, from early-stage startups to clinical-stage companies. Pontifax seeks groundbreaking innovations in the healthcare sector, with a global sourcing approach for identifying promising opportunities.
The firm provides hands-on guidance, networking, and strategic support to maximize portfolio companies' potential for success. Notable investments include Abcuro, Antios Therapeutics, and Keros Therapeutics. Pontifax's investment strategy spans from scouting disruptive ideas in research centers to building exceptional companies, emphasizing entrepreneurship and growth in the life sciences sector.
Pontifax - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
